Navigation Links
Successful Massachusetts Healthcare Reform Initiative Faces Rising Healthcare Costs in Year Two
Date:2/19/2008

Local Healthcare Stakeholders Develop Ideas to Counter Rising Costs,

According to a New Report from HealthLeaders-InterStudy

NASHVILLE, Tenn., Feb. 19 /PRNewswire-USNewswire/ -- HealthLeaders- InterStudy, a leading provider of managed care market intelligence, reports that Massachusetts' ambitious near-universal healthcare reform initiative wrapped up a successful first year, but the rising cost of healthcare and higher-than-expected enrollment threaten to undermine Commonwealth Care and Commonwealth Choice in year two. According to the latest New England Health Plan Analysis, local healthcare officials and Blue Cross Blue Shield of Massachusetts are bringing ideas to the table to address the issues now.

"As concerns have begun to mount over cost, both the health plan and hospital association are attempting to take proactive steps, floating ideas to frame the discussion," states Ric Gross, market analyst for HealthLeaders- InterStudy and author of the report.

Blue Cross Blue Shield of Massachusetts reacted to the issue of rising healthcare costs by announcing it wants to quit paying providers for each visit or treatment, but instead pay a flat payment per patient each year, adjusted for age and sickness. In addition, the health plan said it would pay a significant bonus if the providers improve care.

The health plan association released a comprehensive set of recommendations, and includes a mixture of legislative proposals and voluntary measures, designed to target rising costs. In a 17-point legislative package, the association addresses everything from public reporting and non-billing of preventable errors to making greater use of managed Medicaid. The state's hospital association also tackled the issue, putting forth an agenda that includes efforts for administrative simplification; addressing the workforce shortage, especially as it relates to nurses; and instituting a chronic-care disease management program around
'/>"/>

SOURCE HealthLeaders-InterStudy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Redefining a Products Identity Key to a Successful Re-Launch
2. Kiadis Pharma Announces Successful Completion of Rhitol(TM) Phase II Clinical Study
3. Lilly Caps Successful Year with Strong Fourth-Quarter Results
4. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP
6. Best Practice Database: Complimentary Excerpt of Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles
7. ADA Outlines Successful Environmental Efforts
8. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
9. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
10. Successful Breast-Feeding
11. How one virus uses mimicry to replicate successfully

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...-USNewswire/ -- The American Society of Hematology...on of blood specialists, expects more than 20,000 ...mber 5-8, 2009, at the Ernest N. Morial Convention...ase the latest research and treatments for blood d...51st annual meeting, where we will celebrate the s...
(Date:12/1/2009)...ire/ -- A national survey reveals the majority of ...es and themselves but at the same time want the ri...amilies. ,, See video from HealthyWomen at: ht... of mothers of children aged 12 months and younger...eeding decision prior to going to the hospital to ...
(Date:12/1/2009)...ire/ -- Edifecs, Inc., the proven leader in HIPAA ...s announced an enhanced release of Edifecs XEngine... 5010 migrations. XEngine Translator provides out-...eration of test data and permits two-way translati...ressing most requirements for organizations planni...
(Date:12/1/2009)...creening test, expert says , , TUESDAY, ... lead to a simple blood test to screen for lung ca...em markers that indicate early-stage lung tumors i...searchers examined gene expression profiles in blo...ng cancer and a control group of 91 people with no...
(Date:12/1/2009)...ver surgery after chemo, study finds, , ...f liver tumors caused by the spread of colorectal ...motherapy, researchers report. , Adding bevaciz...shown to improve survival in patients with late-st...s in patients having surgery to remove colorectal ...
Breaking Medicine News(10 mins):Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2
...inal Imaging System Allows Primary Care Physicians...l Images, WAKE FOREST, N.C., Sept. 19 Digital He...se management company based in Wake,Forest, NC, an...(R) technology platform. Retasure is a simple, af...
...IEW, Calif., Sept. 20 Cardiva Medical, Inc.,a pri...y that Augustine,Lien, Chairman and CEO, will pres... on Tuesday, September 25th in New York City. Nota...arket,clearance. This new product builds on the su...
...s Position as the Global Leader in Endoscopic Anti...Surgical, Inc. (NDO),announced that the US Food an...Plicator II(TM) multiple implant technology for im...This clearance and the subsequent launch of next-g...
...., Sept. 21 Cephalon, Inc. (Nasdaq:,CEPH) today a...ion (NDA) to,the U.S. Food and Drug Administration...tine HCl) for the treatment of patients with chron...e United States, according to the National Cancer ...
...) receives FDA clearance, REDMOND, Wash., Sept. 2...X(TM) device for performing Transoral Incisionless...troesophageal reflux,disease has received FDA clea...yesterday under general anesthesia,transoral, inci...
...IV Prof. Ehud Assia, of Tel Aviv Universitys Sack...ar in the field of eye surgery. , One of a small ...orm a complicated form of glaucoma surgery, Prof. ... give most practicing eye surgeons the ability to ...
Other Medicine News:Health News:Digital Healthcare Wins FDA Approval for Retasure 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:NDO Receives FDA 510(K) Clearance for Plicator II(TM) 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Health News:Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:Glaucoma surgery in the blink of an eye 2
(Date:12/1/2009)...rts 90 percent radiation reduction in cardiac CT s... -- Dr. James Earls, a radiologist from Fairfax Ra.... will present the findings of a study that shows ...heart patients received from CT scans compared to ...ill present the study to the annual meeting of the...
(Date:12/1/2009)...ERRY HILL, N.J., Dec. 1 ...urprised and delighted when his radiotherapy treat...20 minutes each day to less than five. Midway thr...ware Valley Urology Cancer Center acquired the r...ogy from Varian Medical Systems (NYSE: VAR ), m...
(Date:12/1/2009)...E, Tenn., Dec. 1 Cumberl...d today that an independently conducted study of A...ous N-acetylcysteine, as a cost-saving treatment f... 12, Number 4 of the peer-reviewed Journal of Med...udy concludes that Acetadote is a less costly trea...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Nanoparticles used in common household items caused genetic damage in mice 10748 1Nanoparticles used in common household items caused genetic damage in mice 10748 2Nanoparticles used in common household items caused genetic damage in mice 10748 3Teen Girls at Higher Risk for STDs 3A Report 61460 1Teen Girls at Higher Risk for STDs 3A Report 61460 2Immunity to Swine Flu May Be Broader Than Thought 61457 1Immunity to Swine Flu May Be Broader Than Thought 61457 2Immunity to Swine Flu May Be Broader Than Thought 61457 3
...Congress of European Hematology,Association (EHA) ...tCall/ --,Immunomedics, Inc. , a biopharmaceutical...es to treat cancer and other serious,diseases, tod...ess,of EHA in Vienna, Austria, showed positive res...L) treated with a new,radioimmunotherapy (RAIT) us...
...ivational Reserve" May Also Affect,Alzheimer,s Ris...ire/ -- A new study,suggests that treating risk fa...lood pressure and diabetes, may slow the progressi...eported today at the,2nd Alzheimer,s Association I...in Washington, DC. , Two new studies presented at ...
Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 2Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 3Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 4Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 6Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 7
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: